Clinical Trials
4 trialsNCT01159067 2019-06-18
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
City of Hope Medical Center
Phase 2 Terminated
NCT01572922 2019-06-11
Massive Iron Deposit Assessment
St. Jude Children's Research Hospital
Phase NA Completed
NCT00602446 2017-12-28
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00658411 2013-04-09
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
Dana-Farber Cancer Institute
Phase NA Terminated